Intravitreal Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration among Japanese Patients

Publisher： Karger

E-ISSN： 1423-0267|220|2|118-124

ISSN： 0030-3755

Source： Ophthalmologica, Vol.220, Iss.2, 2006-02, pp. : 118-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 41, Iss. 1, 2008-10 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Repeated Intravitreal Injection of Triamcinolone for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 38, Iss. 6, 2006-11 ,pp. : 324-328

Karger

Access to resources Recommend Favorite

Detection of Antiranibizumab Antibodies among Patients with Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 232, Iss. 1, 2014-05 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Arterial Thromboembolic Events in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Bevacizumab or Ranibizumab

By  

Ophthalmologica, Vol. 225, Iss. 4, 2011-02 ,pp. : 211-221

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite